Key result
Female sex is linked to ~7-fold higher likelihood of CRT super-response in heart failure.
Why the study?
Clinical and morpho-functional predictors of super-response to cardiac resynchronization therapy in patients with HFrEF in the short-term period after implantation are not well defined.
Observational (n=86)
No
Hazard Ratio: 7.048 (95% CI 1.496–33.206)
p-value: p=0.014
Female sex and QRS width may predict CRT super-response; hypothesis-generating and requires prospective validation before guiding selection.
Aim: To evaluate clinical and morpho-functional predictors of super-response to cardiac resynchronization therapy (CRT) in patients with heart failure and reduced ejection fraction (HFrEF) in the short-term period after implantation. Material and Methods. The study enrolled 86 patients (88.4% men, 54.0 ± 8.9 years mean age, New York Heart Association (NYHA) class II–IV). Patients were examined at baseline and in dynamics (mean follow-up was 10.6 ± 3.6 months). According to the change in left ventricular (LV) end-systolic volume (ESV) patients were divided into two groups: Group I (n = 19) with a decrease in LV ESV ≥ 30% (super-responders (SR) and Group II (n = 67) – decrease in LV ESV < 30% (non-super-responders (non-SR). Parameters of mechanical dyssynchrony (MD) were assessed in the two groups including LV pre-ejection period, interventricular mechanical delay (IVMD), intraventricular delay (IVD). Results. At baseline, traditional parameters of MD were higher in SR: LV pre-ejection period (156.8 ± 35.4 ms vs 135.0 ± 35.6 ms; p = 0.021) and IVMD (73.0 [43.0; 108.0] ms vs 47.0 [19.5; 70.0] ms; p = 0.017). Logistic regression results showed that female gender (HR 7.048; 95% CI 1.496–33.206; p = 0.014) and QRS width (HR 1.017; 95% CI 1.000–1.034; p = 0.048) had an independent association with super-response. Conclusion. In patients with HFrEF, more severe mechanical and electrical dyssynchrony is associated with super-response to CRT in a short-term follow-up period.
No takes yet. Share an insight, caveat, or question.
Евгеньевич et al. (2023) conducted an observational in Heart failure and reduced ejection fraction (HFrEF) (n=86). Female gender (and QRS width / mechanical dyssynchrony) vs. Male gender (and narrower QRS) was evaluated on Super-response to CRT (decrease in LV end-systolic volume ≥30%) (HR 7.048, 95% CI 1.496-33.206, p=0.014). Female gender (HR 7.048) and QRS width (HR 1.017) were independently associated with a super-response to cardiac resynchronization therapy in patients with heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: